Post-Traumatic Stress Disorder: Administration, Clinical and Pharmacological, Organizational and Legal, Pharmaceutical Management, Recent Case Studies

Authors

DOI:

https://doi.org/10.53933/sspmpm.v4i1.123

Keywords:

ICD-11, PTSD, administration, management, pharmacotherapy

Abstract

Administered post-traumatic stress disorder based on ICD-11. The organizational and legal management of post-traumatic stress disorder’s pharmacotherapy based on evidence-based medicine and evidence-based pharmacy was studied. The use of medications to reduce post-traumatic stress disorder’s symptoms is indicated. Analgesics, anxiolytics, antidepressants, anticonvulsants, and drugs from other clinical-pharmacological groups can be used for analgesia, mood improvement, anxiety reduction, and control of hypergaining. Areas of professional reintegration (support in job search, skills training, education, employment, and adaptation to civilian life) have been determined. Legal support in the system of legal relations "doctor-patient-pharmacist-lawyer" indicated in order to achieve a comprehensive and multidimensional approach to the medical and pharmaceutical care of patients with post-traumatic stress disorder. Clinical and pharmacological management in the pharmacotherapy of post-traumatic stress disorder was studied. The further pharmaceutical development of the composition of the new drug based on the known active pharmaceutical ingredients of an analgesic and an antipsychotic is substantiated. Mentioned about the organizational and legal management of social patient-oriented pharmacotherapy, recent case studies of post-traumatic stress disorder in conflict conditions.

Author Biography

Viktoriia Shapovalova, Luhansk State Medical University

Doctor of Pharmaceutical Sciences, Professor, Luhansk State Medical University, Public Organization “Association of Medical and Pharmaceutical law”, both – Ukraine

E-mail: pharm_law@ukr.net

 

References

ICD-11: what’s new? UIPHP. 03.01.222. URL: https://www.uiphp.org.ua/uk/hromadske-zdorovia/podii-ta-anonsy/item/363-mkkh11-shcho-novoho.

Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 1. Р. 1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37 DOI: https://doi.org/10.53933/sspmpm.v2i1.37

Pitman R.K., Rasmusson A.M., Karestan C. K. et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012. Vol.13. No.11. P.769-787. DOI: 10.1038/nrn3339. URL: https://pubmed.ncbi.nlm.nih.gov/23047775/ DOI: https://doi.org/10.1038/nrn3339

Thakur A., Choudhary D., Kumar B. et al. A Review on post-traumatic stress disorder (PTSD): symptoms, therapies and recent case studies. Curr Mol Pharmacol. 2022. Vol.15. No.3. P.502-516. DOI: 10.2174/1874467214666210525160944. URL: https://pubmed.ncbi.nlm.nih.gov/34036925/ DOI: https://doi.org/10.2174/1874467214666210525160944

Wei Qi, Martin Gevonden, Arieh Shalev. Prevention of Post-Traumatic Stress Disorder After Trauma: Current Evidence and Future Directions. Curr Psychiatry Rep. 2016. Vol.18. No.2. P.20. doi: 10.1007/s11920-015-0655-0. URL: https://pubmed.ncbi.nlm.nih.gov/26800995/ DOI: https://doi.org/10.1007/s11920-015-0655-0

Maercker A., Cloitre M., Bachem R. et al. Complex post-traumatic stress disorder. Lancet. 2022. Vol.400. No.10345. P.60-72. DOI: 10.1016/S0140-6736(22)00821-2. URL: https://www.thelancet.com/article/S0140-6736(22)00821-2/fulltext DOI: https://doi.org/10.1016/S0140-6736(22)00821-2

Buhmann C.B., Andersen H.S. Diagnosing and treating post-traumatic stress disorder. Ugeskr Laeger. 2017. Vol.179. No.24. P.V12160914. URL: https://pubmed.ncbi.nlm.nih.gov/28606295/

Helping military personnel with post-traumatic stress disorder. Public Health Center of the Ministry of Health of Ukraine. 10.03.2022. URL: https://phc.org.ua/news/dopomoga-viyskovim-z-posttravmatichnim-stresovim-rozladom

Matyash M.M. A multimodal approach in the treatment of long-term consequences of mine-explosive closed craniocerebral injury and post-traumatic stress disorder in ATO participants. Health-ua.com. 19.01.2018. URL: https://health-ua.com/article/33766-multimodalnij-pdhd-u-lkuvann-vddalenih-nasldkv-mnnovibuhovo-zakrito-cherepn

Khvysyuk O.M., Marchenko V.G., Mykhaylov B.V. Medical assistance to combatants. Kharkiv: DISA Plus, 2019. 576 p.

Skrypnikov A.M., Zhivotovska A.M., Bodnar L.A. et al. Psychiatry and narcology. K.: VSV "Medicine", 2021. 224 p.

Post-traumatic stress disorder. Adapted evidence-based clinical practice. URL: https://www.dec.gov.ua/mtd/posttravmatychnyj-stresovyj-rozlad/

Shapovalov V. Multidisciplinary study of medical errors in the system of legal relations between "Doctor-Patient-Pharmacist-Advocate" during the circulation of drugs. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.2. P.1-11. DOI: https://doi.org/10.53933/sspmpm.v3i2.88. DOI: https://doi.org/10.53933/sspmpm.v3i2.88

Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P. 1–24. DOI: https://doi.org/10.53933/sspmpm.v2i4.69. DOI: https://doi.org/10.53933/sspmpm.v2i4.69

Downloads

Published

2024-01-01

How to Cite

Shapovalova, V. (2024). Post-Traumatic Stress Disorder: Administration, Clinical and Pharmacological, Organizational and Legal, Pharmaceutical Management, Recent Case Studies. SSP Modern Pharmacy and Medicine, 4(1), 1–8. https://doi.org/10.53933/sspmpm.v4i1.123

Issue

Section

Health Sciences